Now available: DEPOHGEN® – Genetic risk screening for post-operative bleeding in dogs

WADDL is excited to introduce DEPOHGEN®, a new test in our catalog that supports safer veterinary surgical outcomes through targeted genetic screening.

Developed by Dr. Michael Court, veterinary pharmacologist and geneticist at Washington State University, DEPOHGEN® detects a specific genetic variant associated with Delayed Post-Operative Hemorrhage (DEPOH) in dogs. Knowing a dog’s DEPOH status prior to surgery can inform the need for prophylactic antifibrinolytic medication, and additional post-op monitoring —especially in sighthounds and certain other breeds at higher risk.

How it works

• Uses PCR technology to detect a risk-associated variant
• Accepts either cheek swab (DNA Collection Brush) or whole blood (EDTA) samples
• Sampling kits are provided free of charge upon test order
• Turn-around time: Results available on Fridays for samples received by Wednesday.

Only the DEPOHGEN® test is authorized for determining DEPOH risk in dogs in the USA.

Now available for ordering

Visit the DEPOHGEN® lab page for complete instructions and specimen submission guidelines or contact our client services team at 509-335-9696.